Company
curatherapeutics.com
Pioneering the Next Generation of Multimodal Immunotherapies to Treat Cancer & Age-Associated Diseases to Improve Healthspan & Increase Longevity
Also known as CURA Therapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- pharmaceutical and biotechnology companies
Claim, correct or request removal
Record updated 17 September 2026
About
CURA Therapeutics is developing the next generation of best/first-in-class multimodal immunotherapies to treat metastatic cancers, pathogen infections, fibrotic diseases, and senescence (longevity).
Products
- Other
- CT101
Loading relationship preview